Medivo Inc., a New York City-based health monitoring platform that connects doctors, consumers and clinical labs, raised a $15m Series B financing.
The round was led by the Merck Global Health Innovation Fund (GHIF), with participation from existing investors Safeguard Scientifics, Inc. (NYSE:SFE) and MentorTech Ventures.
The company, which had raised $7m in Series A financing in late 2011 (read here), intends to use the funds to expand its clinical data platform, enrich analytics services, build out connectivity to additional data sources, enhance its product offerings for physicians and consumers, and develop new patient engagement services.
FinSMEs
18/06/2013